Bladder cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
- 1 February 2022
- journal article
- letter
- Published by Elsevier in Annals of Oncology
- Vol. 33 (5) , 561-563
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Bladder cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upAnnals of Oncology, 2022
- Consultation on UTUC, Stockholm 2018: aspects of treatmentWorld Journal of Urology, 2019
- Pembrolizumab as Neoadjuvant Therapy Before Radical Cystectomy in Patients With Muscle-Invasive Urothelial Bladder Carcinoma (PURE-01): An Open-Label, Single-Arm, Phase II StudyJournal of Clinical Oncology, 2018
- Who Should Be Investigated for Haematuria? Results of a Contemporary Prospective Observational Study of 3556 PatientsEuropean Urology, 2018
- Is Exam under Anesthesia Still Necessary for the Staging of Bladder Cancer in the Era of Modern Imaging?Bladder Cancer, 2015
- Variant (divergent) histologic differentiation in urothelial carcinoma is under-recognized in community practice: Impact of mandatory central pathology review at a large referral hospitalUrologic Oncology: Seminars and Original Investigations, 2013